The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21)

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-01, Vol.12 (3), p.357
• Main Authors: Kaczmarska, Agnieszka, Derebas, Justyna, Pinkosz, Michalina, Niedźwiecki, Maciej, Lejman, Monika
• Format: Article
• Language: English
• Subjects: Acute lymphoblastic leukemia; ALL; Antigens; Blood; Blood platelets; Bone marrow; Burkitt Lymphoma; Child; Children; Chromosome 4; Chromosome Aberrations; Chromosome rearrangements; Chromosome translocations; Chromosomes; Core Binding Factor Alpha 2 Subunit - genetics; Core Binding Factor Alpha 2 Subunit - metabolism; Cultural differences; Development and progression; Etiology; ETV6::RUNX1; Gene expression; Genetic aspects; Humans; Leukemia; Leukemia in children; Lymphatic leukemia; Lymphocytes B; Lymphocytic leukemia; Medical prognosis; Molecular modelling; Mutation; Oncogene Proteins, Fusion - genetics; Oncogene Proteins, Fusion - metabolism; Patients; Pediatric research; Pediatrics; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology; Proteins; Review; Runx1 protein; Thrombocytopenia; Transcription factors; Translocation, Genetic; Trisomy
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12030357

The most frequent chromosomal rearrangement in childhood B-cell acute lymphoblastic leukemia (B-ALL) is translocation t(12;21)(p13;q22). It results in the fusion of the gene, which is active in the regulation of multiple crucial cellular pathways. Recent studies hypothesize that many translocations are influenced by RAG-initiated deletions, as well as defects in the RAS and NRAS pathways. According to a "two-hit" model for the molecular pathogenesis of pediatric -positive B-ALL, the t(12;21) translocation requires leukemia-causing secondary mutations. Patients with :: express up to 60 different aberrations, which highlights the heterogeneity of this B-ALL subtype and is reflected in differences in patient response to treatment and chances of relapse. Most studies of secondary genetic changes have concentrated on deletions of the normal, non-rearranged allele. Other predominant structural changes included deletions of chromosomes 6q and 9p, loss of entire chromosomes X, 8, and 13, duplications of chromosome 4q, or trisomy of chromosomes 21 and 16, but the impact of these changes on overall survival remains unclarified. An equally genetically diverse group is the recently identified new B-ALL subtype :: -like ALL. In our review, we provide a comprehensive description of recurrent secondary mutations in pediatric B-ALL with t(12;21) to emphasize the value of investigating detailed molecular mechanisms in -positive B-ALL, both for our understanding of the etiology of the disease and for future clinical advances in patient treatment and management.